# Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer

> **NCT00524186** · PHASE1 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 23 (actual)

## Conditions studied

- Esophageal Cancer
- Gastric Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium
- **DRUG:** sunitinib malate
- **OTHER:** flow cytometry
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00524186
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2013-08
- **Final completion:** 2016-04
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** PI left institute
- **Last updated:** 2016-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524186, "Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00524186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*